Met Life Investment Management, LLC Adicet Bio, Inc. Transaction History

Met Life Investment Management, LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Apr 29, 2024	BUY	$2.13 - $7.13 $34,065 - $114,030	15,993 New	15,993 $38,000
Q1 2023 May 09, 2024	BUY	$5.52 - $9.23 $88,281 - $147,615	15,993 New	15,993 $92.1 Million
Q4 2022 May 10, 2024	BUY	$7.72 - $21.27 $25,290 - $69,680	3,276 Added 25.76%	15,993 $142,000
Q4 2022 Mar 22, 2023	BUY	$7.72 - $21.27 $25,290 - $69,680	3,276 Added 25.76%	15,993 $142,000
Q4 2022 Feb 15, 2023	BUY	$7.72 - $21.27 $25,290 - $69,680	3,276 Added 25.76%	15,993 $142,000
Q3 2022 Jun 14, 2023	SELL	$13.43 - $18.74 $43,996 - $61,392	-3,276 Reduced 20.48%	12,717 $180,000
Q2 2022 Jun 20, 2023	SELL	$10.26 - $20.81 $33,611 - $68,173	-3,276 Reduced 20.48%	12,717 $185,000
Q1 2022 May 10, 2024	BUY	$11.53 - $19.97 $146,627 - $253,958	12,717 New	12,717 $253,000
Q1 2022 Jun 20, 2023	SELL	$11.53 - $19.97 $37,772 - $65,421	-3,276 Reduced 20.48%	12,717 $253,000
Q1 2022 Mar 22, 2023	BUY	$11.53 - $19.97 $52,542 - $91,003	4,557 Added 55.85%	12,717 $253,000
Q1 2022 May 12, 2022	BUY	$11.53 - $19.97 $52,542 - $91,003	4,557 Added 55.85%	12,717 $254,000
Q4 2021 May 17, 2024	BUY	$7.37 - $17.49 $60,139 - $142,718	8,160 New	8,160 $142,000
Q4 2021 Jun 21, 2023	SELL	$7.37 - $17.49 $57,729 - $136,999	-7,833 Reduced 48.98%	8,160 $142,000
Q4 2021 Mar 22, 2023	SELL	$7.37 - $17.49 $57,729 - $136,999	-7,833 Reduced 48.98%	8,160 $142,000
Q4 2021 Feb 15, 2022	BUY	$7.37 - $17.49 $60,139 - $142,718	8,160 New	8,160 $143,000

59.2M

4.2K

6.7K

Ticker ACET
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,030,800
Market Cap $39.6M
Description
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Met Life Investment Management, LLC with notifications on news.